ArticleNaunyn-Schmiedeberg's archives of pharmacology2025
Effects of empagliflozin and its combination with docetaxel on LNCaP and DU- 145 prostate cancer cell lines: cytotoxicity and molecular pathway analysis.
Ahmet Cumaoğlu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.